Per-Operative Levosimendan Use In High-Risk Patients Undergoing Coronary Artery Bypass Surgery Yüksek Riskle Koroner Arter Cerrahisi Uygulanan Hastalarda Per-Operatif Levosimendan Kullanımı

1 Istanbul University, Institute of Cardiology, Department of Cardiovascular Surgery 2 Istanbul University, Institute of Cardiology, Department of Cardiology 3 Istanbul University, Institute of Cardiology, Department of Anesthesiology and Reanimation Aim: Although conventional inotropic drugs are well examined for myocardial support during weaning from cardiopulmonary bypass (CPB), there is limited experience about a new calcium sensitiser drug, levosimendan. We aimed to investigate effects of early infusion of ‘levosimendan’ started per-operatively without a loading dose, on outcomes of patients experiencing difficultly to wean from CPB after coronary artery bypass grafting (CABG).